Basic Theory of Chinese Medicine, Preclinical Medicine School, Beijing University of Chinese Medicine, Beijing 100029, China.
Diabetes Research Center, Beijing University of Chinese Medicine, Beijing 100029, China.
Evid Based Complement Alternat Med. 2014;2014:475192. doi: 10.1155/2014/475192. Epub 2014 Jun 25.
Diabetes mellitus (DM), a kind of metabolic disease, is increasing over the last four decades in the world. The purpose of this study was to investigate the effect of Jiang Tang Xiao Ke (JTXK) granule, a naturally occurring ingredient from Chinese herbal medicines, on serum glucose, lipids, and oxidative stress in DM rats induced by high-fat diet and streptozotocin. JTXK granule 9 g/kg (based on crude herb equivalent) and pioglitazone 1.5 mg/kg (as a positive control for comparison) were orally administrated to DM rats for 4 weeks. Results showed that administration of JTXK granule reduced serum glucose, total cholesterol, triglyceride, and low density lipoprotein levels (by 12%, 33%, 57%, and 44%, resp.) but increased high-density lipoprotein level by 69%, compared with the drug-untreated DM rats. Serum malondialdehyde and nitric oxide levels were lowered (by 34% and 52%, resp.) associated with the elevation in serum superoxide dismutase levels (by 60%) after JTXK granule treatment. In addition, JTXK granule suppressed serum alanine aminotransferase activity (up to 50%) and alleviated pathological changes of pancreas and liver tissues in DM rats. The beneficial changes of pioglitazone on biomarkers were also found in DM rats. These findings suggested that JTXK granule may be an alternative medicine for the management of DM.
糖尿病(DM)是一种代谢疾病,在过去四十年中在世界范围内不断增加。本研究旨在探讨降糖消瘕(JTXK)颗粒对高脂肪饮食和链脲佐菌素诱导的 DM 大鼠血清葡萄糖、血脂和氧化应激的影响。JTXK 颗粒 9g/kg(基于生药当量)和吡格列酮 1.5mg/kg(作为阳性对照进行比较)灌胃给药 4 周。结果表明,与未用药 DM 大鼠相比,JTXK 颗粒可降低血清葡萄糖、总胆固醇、甘油三酯和低密度脂蛋白水平(分别降低 12%、33%、57%和 44%),同时增加高密度脂蛋白水平(增加 69%)。JTXK 颗粒治疗后血清丙氨酸氨基转移酶活性降低(降低 50%),血清丙二醛和一氧化氮水平降低(分别降低 34%和 52%),血清超氧化物歧化酶水平升高(升高 60%)。此外,JTXK 颗粒还可缓解 DM 大鼠胰腺和肝脏组织的病理变化。DM 大鼠中也发现吡格列酮对生物标志物的有益变化。这些发现表明,JTXK 颗粒可能是治疗糖尿病的一种替代药物。